Frontlight ResearchEarly access
Retinitis pigmentosa trials in Indonesia
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in IndonesiaLong-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
- Where
- Jakarta, Yogyakarta
- Age
- 18 years to 65 years
- People
- 18
- Run by
- PT. Prodia Stem Cell Indonesia
See details and how to joinNCT05786287 - Phase 2/3Not yet taking people in IndonesiaRole of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II
- Where
- Yogyakarta
- Age
- 18 years to 65 years
- People
- 30
- Run by
- PT. Prodia Stem Cell Indonesia
See details and how to joinNCT05909488